Please login to the form below

Not currently logged in
Email:
Password:

DAVID

This page shows the latest DAVID news and features for those working in and with pharma, biotech and healthcare.

Amgen’s Lumakras shows promise in phase 3 lung cancer study

Amgen’s Lumakras shows promise in phase 3 lung cancer study

David Reese, executive vice president of research and development at Amgen, said: "This data presented at ASCO underscores the clinical importance of Lumakras, including the only randomised trial of a KRAS

Latest news

More from news
Approximately 7 fully matching, plus 849 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 79 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 152 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 114 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Anthem PR

With a rare strength in media and influencer relations, Anthem’s award-winning team offers a fresh approach to health PR...

Latest intelligence

Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
Tuberculosis – why it remains a major global public health challenge
Innovative collaboration is required to address the major public health challenges around TB and expedite drug development...
Whitepaper: Closing the gap with compelling healthcare communications
Want to learn how to close the distance between a person’s current health and their healthiest possible self?...